Smart pH-responsive nanomedicines for disease therapy

다국어 초록 (Multilingual Abstract)

Background Currently nanomedicines are the focus of attention from researchers and clinicians because of the successes of lipid-nanoparticles-based COVID-19 vaccines. Nanoparticles improve existing treatments by providing a number of advantages including protection of cargo molecules from external stresses, delivery of drugs to target tissues, and sustained drug release. To prevent premature release-related side effects, stable drug loading in nanoformulations is required, but the increased stability of the formulation could also lead to a poor drug-release profile at the target sites. Thus, researchers have exploited differences in a range of properties (e.g., enzyme levels, pH, levels of reduced glutathione, and reactive oxygen species) between non-target and target sites for site-specific release of drugs. Among these environmental stimuli, pH gradients have been widely used to design novel, responsive nanoparticles.
Area covered In this review, we assess drug delivery based on pH-responsive nanoparticles at the levels of tissues (tumor microenvironment, pH ~ 6.5) and of intracellular compartments (endosome and lysosome, pH 4.5–6.5). Upon exposure to these pH stimuli, pH-responsive nanoparticles respond with physicochemical changes to their material structure and surface characteristics. These changes include swelling, dissociation, or surface charge switching, in a manner that favors drug release at the target site (the tumor microenvironment region and the cytosol followed by endosomal escape) rather than the surrounding tissues.
Expert opinion Lastly, we consider the challenges involved in the development of pH-responsive nanomedicines.

참고문헌 (Reference)

1 Gu J, "pHtriggered reversible"stealth"polycationic micelles" 9 : 255-262, 2008

2 Wu H, "pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery" 34 : 1213-1222, 2013

3 Zhuo S, "pH-sensitive biomaterials for drug delivery" 25 : 5696-, 2020

4 Convertine AJ, "pH-responsive polymeric micelle carriers for siRNA drugs" 11 : 2904-2911, 2010

5 Deirram N, "pH-Responsive polymer nanoparticles for drug delivery" 40 : e1800917-, 2019

6 Gao W, "pH-Responsive nanoparticles for drug delivery" 7 : 1913-1920, 2010

7 Yan Y, "pH-Responsive nanoparticles for cancer immunotherapy : a brief review" 10 : 1613-, 2020

8 Wilson JT, "pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides" 7 : 3912-3925, 2013

9 Chaudhary N, "mRNA vaccines for infectious diseases : principles, delivery and clinical translation" 20 : 817-838, 2021

10 Reichmuth AM, "mRNA vaccine delivery using lipid nanoparticles" 7 : 319-334, 2016

11 Bruyere H, "Tuning the pH sensitivities of orthoester based compounds for drug delivery applications by simple chemical modification" 20 : 2200-2203, 2010

12 Wu XL, "Tumortargeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy" 21 : 208-213, 2010

13 Wang X, "Tumor-microenvironment-activated in situ self-assembly of sequentially responsive biopolymer for targeted photodynamic therapy" 2020

14 Thews O, "Tumor pH and metastasis : a malignant process beyond hypoxia" 38 : 113-129, 2019

15 Thomas RG, "Tumor microenvironment-stimuli responsive nanoparticles for anticancer therapy" 7 : 610533-, 2020

16 He Q, "Tumor microenvironment responsive drug delivery systems" 15 : 416-448, 2020

17 Gallon E, "Triblock copolymer nanovesicles for pH-responsive targeted delivery and controlled release of siRNA to cancer cells" 16 : 1924-1937, 2015

18 Farhood H, "The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer" 1235 : 289-295, 1995

19 Damase TR, "The limitless future of RNA therapeutics" 9 : 628137-, 2021

20 Ward C, "The impact of tumour pH on cancer progression : strategies for clinical intervention" 1 : 71-100, 2020

21 Hu YB, "The endosomal-lysosomal system : from acidification and cargo sorting to neurodegeneration" 4 : 18-, 2015

22 Christofk HR, "The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth" 452 : 230-233, 2008

23 Cui JW, "Templated Assembly of pH-Labile Polymer-Drug Particles for Intracellular Drug Delivery" 22 : 4718-4723, 2012

24 Oishi M, "Synthesis, characterization, and biomedical applications of core-shell-type stimuli-responsive nanogels-Nanogel composed of poly[2-(N, N-diethylamino)ethyl methacrylate] core and PEG tethered chains" 67 : 1311-1329, 2007

25 Mura S, "Stimuli-responsive nanocarriers for drug delivery" 12 : 991-1003, 2013

26 Zhang YN, "Self-organized nanoparticle drug delivery systems from a folate-targeted dextran-doxorubicin conjugate loaded with doxorubicin against multidrug resistance" 5 : 71164-71173, 2015

27 Zhao ZX, "Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine(R15)triblock copolymer for siRNA delivery" 33 : 6793-6807, 2012

28 Park S, "Reversibly pH-responsive gold nanoparticles and their applications for photothermal cancer therapy" 9 : 20180-, 2019

29 Chauhan VP, "Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy" 116 : 10674-10680, 2019

30 Xu M, "Reduction/pH dual-sensitive PEGylated hyaluronan nanoparticles for targeted doxorubicin delivery" 98 : 181-188, 2013

31 Qin X, "Rational design of nanocarriers for intracellular protein delivery" 31 : e1902791-, 2019

32 Kodama Y, "Quaternary complexes modified from pDNA and polyl-lysine complexes to enhance pH-buffering effect and suppress cytotoxicity" 104 : 1470-1477, 2015

33 Tao Y, "Pseudo target release behavior of simvastatin through pH-responsive polymer based on dynamic imine bonds : promotes rapid proliferation of osteoblasts" 113 : 110979-, 2020

34 Shen Y, "Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery" 132 : 4259-4265, 2010

35 Aryal S, "Polymer–cisplatin conjugate nanoparticles for acid-responsive drug delivery" 4 : 251-258, 2010

36 Chen X, "PolyMPC-doxorubicin prodrugs" 23 : 1753-1763, 2012

37 Zheng M, "Poly(ethylene oxide)grafted with short polyethylenimine gives DNA polyplexes with superior colloidal stability, low cytotoxicity, and potent in vitro gene transfection under serum conditions" 13 : 881-888, 2012

38 Liang K, "Peptide-tunable drug cytotoxicity via one-step assembled polymer nanoparticles" 26 : 2398-2402, 2014

39 Mishra S, "PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles" 83 : 97-111, 2004

40 Lee Y, "Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome" 179 : 114021-, 2021

41 Lomas H, "Non-cytotoxic polymer vesicles for rapid and efficient intracellular delivery" 139 : 143-159, 2008

42 Gao Y, "Nanotechnology-enabled COVID-19 mRNA vaccines" 1 : 773-780, 2021

43 Li B, "Nanoscale platforms for messenger RNA delivery" 11 : e1530-, 2019

44 Wu Z, "Nanoparticle-mediated cytoplasmic delivery of messenger RNA vaccines : challenges and future perspectives" 38 : 473-478, 2021

45 Zhao L, "Nanoparticle vaccines" 32 : 327-337, 2014

46 Laura I. Selby, "Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles" Wiley 9 (9): 2017

47 Han X, "Modularly designed peptide nanoprodrug augments antitumor immunity of PD-L1checkpoint blockade by targeting indoleamine 2, 3-dioxygenase" 142 : 2490-2496, 2020

48 Cong Y, "Microenvironment-induced in situ self-assembly of polymer-peptide conjugates that attack solid tumors deeply" 58 : 4632-4637, 2019

49 Zelphati O, "Mechanism of oligonucleotide release from cationic liposomes" 93 : 11493-11498, 1996

50 Zhang J, "Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer : core-shell nanoparticle carrier and drug release response" 3 : 838-850, 2007

51 Zhang X, "Macromolecular pHPMA-based nanoparticles with cholesterol for solid tumor targeting : behavior in HSA protein environment" 19 : 470-480, 2018

52 Balazs DA, "Liposomes for use in gene delivery" 2011 : 326497-, 2011

53 Cullis PR, "Lipid polymorphism and the roles of lipids in membranes" 40 : 127-144, 1986

54 Aldosari BN, "Lipid nanoparticles as delivery systems for RNA-based vaccines" 13 (13): 206-, 2021

55 Torchilin V, "Intracellular delivery of protein and peptide therapeutics" 5 : e95-e103, 2008

56 Su X, "In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles" 8 : 774-787, 2011

57 Cheng C, "Imine bondand coordinate bond-linked pH-sensitive cisplatin complex nanoparticles for active targeting to tumor cells" 19 : 3277-3287, 2019

58 Filippov SK, "Hydrolytically degradable polymer micelles for drug delivery : a SAXS/SANS kinetic study" 14 : 4061-4070, 2013

59 Li W, "GALA : a designed synthetic pHresponsive amphipathic peptide with applications in drug and gene delivery" 56 : 967-985, 2004

60 White JM, "Fusion of enveloped viruses in endosomes" 17 : 593-614, 2016

61 Griset AP, "Expansile nanoparticles : synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system" 131 : 2469-2471, 2009

62 Nakase I, "Endosome-disruptive peptides for improving cytosolic delivery of bioactive macromolecules" 94 : 763-770, 2010

63 Murphy RF, "Endosome pH measured in single cells by dual fluorescence flow cytometry : rapid acidification of insulin to pH 6" 98 : 1757-1762, 1984

64 Diering GH, "Endosomal pH in neuronal signaling and synaptic transmission : role of Na(+)/H(+)exchanger NHE5" 4 : 412-, 2014

65 Sakurai Y, "Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA" 32 : 5733-5742, 2011

66 Wu W, "Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications" 8 : 3038-3058, 2018

67 Canton I, "Endocytosis at the nanoscale" 41 : 2718-2739, 2012

68 Danial M, "Effect of the amino acid composition of cyclic peptides on their self-assembly in lipid bilayers" 13 : 2464-2473, 2015

69 Wang HM, "Dual-responsive nanoparticles based on oxidized pullulan and a disulfide-containing poly(beta-amino)ester for efficient delivery of genes and chemotherapeutic agents targeting hepatoma" 7 : 6340-6353, 2016

70 Sun CY, "Doxorubicin conjugate of poly(ethylene glycol)-block-polyphosphoester for cancer therapy" 3 : 261-272, 2014

71 Li M, "Discovery and characterization of a peptide that enhances endosomal escape of delivered proteins in vitro and in vivo" 137 : 14084-14093, 2015

72 Sato Y, "Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E/low density lipoprotein receptor and the N-acetyl-D-galactosamine/asialoglycoprotein receptor pathway" 322 : 217-226, 2020

73 Pack DW, "Design and development of polymers for gene delivery" 4 : 581-593, 2005

74 Kanasty R, "Delivery materials for siRNA therapeutics" 12 : 967-977, 2013

75 Zhou X, "DNA transfection mediated by cationic liposomes containing lipopolylysine : characterization and mechanism of action" 1189 : 195-203, 1994

76 Hu Y, "Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles" 7 : 3056-3064, 2007

77 Hu Y, "Cytosolic delivery mediated via electrostatic surface binding of protein, virus, or siRNA cargos to pH-responsive core-shell gel particles" 10 : 756-765, 2009

78 Massignani M, "Controlling cellular uptake by surface chemistry, size, and surface topology at the nanoscale" 5 : 2424-2432, 2009

79 Hudlikar MS, "Controlled multi-functionalization facilitates targeted delivery of nanoparticles to cancer cells" 22 : 1415-1423, 2016

80 Zhang X, "Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment" 8 : 1885-1896, 2020

81 Sugahara KN, "Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs" 328 : 1031-1035, 2010

82 Yang J, "Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates" 321 : 462-468, 2007

83 Song LY, "Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes" 1558 : 1-13, 2002

84 Lundberg M, "Cell surface adherence and endocytosis of protein transduction domains" 8 : 143-150, 2003

85 Kim JW, "Cancer’s molecular sweet tooth and the Warburg effect" 66 : 8927-8930, 2006

86 Sebastiani F, "Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles" 15 : 6709-6722, 2021

87 Koltover I, "An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery" 281 : 78-81, 1998